SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
HALT PETER

(Last) (First) (Middle)
C/O ROVI CORPORATION
2 CIRCLE STAR WAY

(Street)
SAN CARLOS CA 94070

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Rovi Corp [ ROVI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CFO
3. Date of Earliest Transaction (Month/Day/Year)
03/01/2016
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/01/2016 M 1,065(1) A $0.001 148,356(2) D
Common Stock 03/01/2016 M 13,516(3) A $0.001 161,872 D
Common Stock 03/01/2016 M 7,000(4) A $0.001 168,872 D
Common Stock 03/01/2016 F 19,482(5) D $23.44 149,390 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (6) 03/01/2016 A 18,297 (7) 03/01/2020 Common Stock 18,297 $0 18,297 D
Performance Rights (6) 03/01/2016 A 18,297 (8) 03/01/2019 Common Stock 18,297 $0 18,297 D
Employee Stock Option (Right to Buy) $23.44 03/01/2016 A 22,195 (9) 03/01/2023 Common Stock 22,195 $0 22,195 D
Performance Rights (10) 03/01/2016 M 1,065(1) 03/01/2016 03/01/2016 Common Stock 1,065 $0 0 D
Performance Rights (10) 03/01/2016 M 13,516(3) 03/01/2016 03/01/2017 Common Stock 13,516 $0 19,034 D
Restricted Stock Units (6) 03/01/2016 M 7,000(4) 03/01/2016 03/01/2019 Common Stock 7,000 $0 21,000 D
Explanation of Responses:
1. Awarded 85% of target based upon performance metrics from the July 1, 2012 performance grant. 1,065 shares are releaseable on March 1, 2016.
2. Includes 2,371 shares purchased on January 29, 2016 pursuant to the company's Employee Stock Purchase Plan (ESPP).
3. Awarded 90% of target based upon performance metrics from the March 1, 2013 performance grant. 13,516 shares are releaseable on March 1, 2016.
4. Granted March 1, 2015, this restricted stock unit grant vests over 4 years with 25% vesting on each of the annual anniversaries of the grant date.
5. Shares withheld to satisfy tax withholding obligations upon vesting of restricted stock.
6. Each restricted stock unit represents a contingent right to receive one share of ROVI common stock.
7. Granted March 1, 2016, this restricted stock unit grant vests over 4 years with 25% vesting on each of the annual anniversaries of the grant date.
8. Granted March 1, 2016, these performance awards are based entirely on a three-year performance period and are eligible to vest after three years based upon the achievement of the following two factors, each weighted equally: (i) a three-year relative TSR metric of percentile ranking against a peer group established by our compensation committee, and (ii) three-year revenue compound annual growth rate and margin targets.
9. Granted March 1, 2016, vests one-fourth (1/4) on the first anniversary of the date of grant and the remaining three-fourths (3/4) vesting in equal monthly increments over the next three years.
10. Each restricted stock award share represents a contingent right to receive one share of ROVI common stock.
Remarks:
Bonnie J. Bigelow Attorney-in-Fact for Peter Halt 03/03/2016
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.